"/> Invitrogen™ Peptide synthétique TRAF3IP2 humain | B-LABO France

Invitrogen™ Peptide synthétique TRAF3IP2 humain

Réf. : BL-RE-176417Réf. fabricant : 15226339 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
10758
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
O43734
Nom usuel
Human TRAF3IP2
Marque
Invitrogen

CIKS Synthetic Peptide, PEP-0112, from Invitrogen.

This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Two alternative transcripts encoding different proteins have been identified. A third transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176417
Réf. fabricant15226339
Gene ID (Entrez)10758
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionO43734
Nom usuelHuman TRAF3IP2
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)TRAF3IP2
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.